Morphic Announces Appointment of Marc Schegerin, M.D., as Chief Financial Officer and Chief Operating Officer

    NEXT STORY
    La Jolla Pharmaceutical Company to Provide GIAPREZA™ (Angiotensin II) for Named Patient Emergency Use in Patients with Septic Shock Due to COVID-19 at University Hospital Münster in Germany
    PREV STORY
    Ventilator Demand has Soared Amid the COVID-19 Pandemic: How are Manufacturers Meeting Demand? – ResearchAndMarkets.com
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Marina Biotech Announces Binding Letter of Intent for the Sale of its DiLA2 Delivery Platform

    CITY OF INDUSTRY, Calif., July 25, 2017 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB:MRNA), ...

    author_avatar
    NASDAQ Market News

    PRA Health Sciences ernennt hochrangigen FDA-Beamten zum Leiter des neuen Global Center of Excellence for Decentralized Clinical Trial Strategy

    author_avatar
    NASDAQ Market News

    ERC Launches Development Program for Novel Cell-Based Therapeutic and Prophylactic SARS-CoV-2 Vaccine

    author_avatar
    NASDAQ Market News